Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer’s disease-related phenotypes

Read full text
Authors: Yun Lei, Yuting Chen, Ming‐Lei Guo, Florikaben Patel, Yu Bai, Brandee M. S. S. Goo, Quansheng Du, Neal L. Weintraub, Xin‐Yun Lu
Cited by: 1
References: 125

Abstract

Epigenetic regulation is a key determinant of the aging process, and its dysregulation contributes to cognitive aging and increased vulnerability to Alzheimer's disease (AD). As major regulators of epigenetic processes, histone deacetylases (HDACs) have emerged as potential therapeutic targets for cognitive enhancement in neurodegenerative diseases. However, the distinct roles of individual HDAC isoforms remain to be defined. Here, we report that HDAC9 is specifically expressed in neurons of human and mouse brains, and its expression declines with age. HDAC9 deficiency impairs cognitive function and synaptic plasticity in young mice. Selective deletion of HDAC9 in hippocampal CA1 neurons also induces cognitive impairment. In contrast, overexpression of HDAC9 in forebrain glutamatergic neurons preserves cognitive function in aged mice. Moreover, HDAC9 is also downregulated in the brain of AD mouse models, whereas neuronal overexpression of HDAC9 alleviates AD-related cognitive and synaptic deficits and reduces Aβ deposition. Together, these findings suggest neuronal HDAC9 is necessary and sufficient for maintaining cognitive and synaptic functions in the context of aging and AD.

Fields of Study & Subjects

Histone Deacetylase Inhibitors Research Alzheimer's disease research and treatments Tryptophan and brain disorders

Publication details

Journal / source
Molecular Psychiatry
Publisher
Springer Science and Business Media LLC
Volume
31
Issue
8
Pages
4699–4715
Publication date
4 April 2026
Language
EN